BCAB Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 108686 min ago

@ $2.35

Wydano: 14 vas. 2024 @ 16:33

Zwrot: 9.79%

Poprzedni sygnał: vas. 12 - 17:14

Poprzedni sygnał: Kupno

Zwrot: -12.31 %

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 23:00):

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer...

Stats
Dzisiejszy wolumen	465 712
Średni wolumen	550 124
Kapitalizacja rynkowa	124.11M
EPS	$0 ( 2024-03-26 )
Następna data zysków	( $-0.570 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.000
ATR14	$0.00400 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Smith Scott Andrew	Sell	2 181	Common Stock
2024-03-31	Sievers Eric	Sell	572	Common Stock
2024-02-29	Smith Scott Andrew	Sell	2 181	Common Stock
2024-02-29	Sievers Eric	Sell	572	Common Stock
2024-02-15	Waldron Richard A	Buy	106 000	Common Stock

INSIDER POWER
93.82
Last 100 transactions
Buy: 3 003 180 \| Sell: 92 181

Wolumen Korelacja

Długi: -0.12 (neutral)

Krótki: -0.20 (neutral)

Signal:(55.149) Neutral

BioAtla, Inc. Korelacja

10 Najbardziej pozytywne korelacje
GOSS	0.966
ODT	0.962
SWAV	0.95
TRVN	0.944
XFOR	0.944
THTX	0.941
PAVM	0.935
LYRA	0.933
TCDA	0.931
ENPH	0.931

10 Najbardziej negatywne korelacje
MLCO	-0.965
ITMR	-0.954
AVEO	-0.95
CCRC	-0.946
TOUR	-0.946
LUNA	-0.941
ACAB	-0.938
TCMD	-0.937
RXDX	-0.937
ALXN	-0.937

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioAtla, Inc. Korelacja - Waluta/Towar

-0.60
( weak negative )

-0.64
( weak negative )

0.00
( neutral )

0.78
( moderate )

BioAtla, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-1.22M (0.00 %)
EPS:	$-2.58

FY	2023
Przychody:	$0
Zysk brutto:	$-1.22M (0.00 %)
EPS:	$-2.58

FY	2022
Przychody:	$0
Zysk brutto:	$-1.20M (0.00 %)
EPS:	$-2.70

FY	2021
Przychody:	$250 000
Zysk brutto:	$250 000 (100.00 %)
EPS:	$0

Financial Reports:

No articles found.

BioAtla, Inc.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.